Press release
Chronic Pain Therapeutics Market Size in the 7MM is anticipated to increase by 2034 and according to DelveInsight
Unlock key insights into the Chronic Pain Market! Download DelveInsight's comprehensive report to explore market trends, pipeline analysis, and emerging therapies @ Chronic Pain Market Size [https://www.delveinsight.com/sample-request/chronic-pain-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=ypr]
Key Takeaways from the Chronic Pain Market Report
* In November 2024:- Evon Medics LLC- The overarching goal of this study phase, Phase II component is to perform a randomized clinical trial of the refined Computerized Chemosensory-Based Orbitofrontal Networks Training for Treatment of Pain [CBOT-Pain (or CBOT-P)] from Phase I, compared to sham Computerized Chemosensory-Based Orbitofrontal Networks Training (CBOT) in Chronic Low Back Pain (CLBP) to determine its short- and long-term effectiveness on Pain, Negative Affect (NA), Cognition and Cortical Brain Structure (PACS), long-term safety, and indications.
* In November 2024:- Hanmi Pharmaceutical Company Limited- A Randomized, Double-blind, Active-controlled, Non-inferiority, Multicenter Phase III Study to Evaluate the Efficacy and Safety of HCP1004 as compared to RLD2401 in Chronic Low-Back Pain Patients.
* The total 7MM Chronic Pain Prevalent Cases in 2023 US accounted the highest cases.
* Among the EU4 and the UK, the highest number of Chronic Pain prevalent cases were observed in the UK ~ 30%.
* Prevalence of chronic pain increased with age and was higher among those in age group between 45-64 years.
* Approximately 70% of chronic pain cases in the United States in 2023 fall within the category of moderate to severe severity-specific cases.
* The Chronic Pain Companies such as AbbVie, Paradigm Biopharmaceuticals Ltd., Noven Pharmaceuticals, Pfizer, Anika Therapeutics, Biogen, Tonix Pharmaceuticals, Taiwan Liposome Company, Centrexion Therapeutics, Braeburn Pharmaceuticals, Regeneron, Teva Pharmaceuticals, Mitsubishi Tanabe Pharma Corporation, Vertanical GmbH , and others.
* Promising Chronic Pain Therapies such as Secukinumab, AbobotulinumtoxinA, Rexlemestrocel-L + HA mixture, IncobotulinumtoxinA, Retatrutide , and others.
Stay ahead in the competitive landscape of the Chronic Pain Market. Access DelveInsight's in-depth market analysis and strategic insights today! Click here for more @ Chronic Pain Treatment Market Size [https://www.delveinsight.com/sample-request/chronic-pain-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=ypr]
Chronic Pain Epidemiology Segmentation in the 7MM
* Total Chronic Pain Prevalent Cases
* Total Chronic Pain Diagnosed Cases
* Chronic Pain Severity-specific Cases
* Chronic Pain Age-specific Cases
* Chronic Pain Cause-specific Cases
Download the report to understand which factors are driving Chronic Pain epidemiology trends @ Chronic Pain Prevalence [https://www.delveinsight.com/sample-request/chronic-pain-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=ypr]
Chronic Pain Marketed Drugs
* JOYCLU (diclofenac etalhyaluronate sodium): Seikagaku Corporation/Chiltern International
JOYCLU is a formulation in which hyaluronic acid and diclofenac (an anti-inflammatory drug) are chemically bound using Seikagaku's proprietary technology. It is designed to release diclofenac by hydrolysis in the joint. Improvement of symptoms of osteoarthritis (knee joint and hip joint) is expected by administering JOYCLU into the joint cavity once every 4 weeks. JOYCLU is the first joint function improvement agent in Japan to treat osteoarthritis of the hip joint.
* ZILRETTA (triamcinolone acetonide extended-release injectable suspension): Pacira BioSciences
ZILRETTA (triamcinolone acetonide extended-release injectable suspension) is an intra-articular injection to manage osteoarthritis pain in the knee. ZILRETTA is Flexion's novel, proprietary, sustained-release formulation composed of triamcinolone acetonide (TA) embedded in a biodegradable PLGA matrix that extends residence time in the joint for the treatment of mild-to-moderate OA of the knee. ZILRETTA received approval from the FDA on October 2017.
Chronic Pain Emerging Drugs
* ZILOSUL (pentosan polysulfate sodium): Paradigm Biopharmaceuticals.
Pentosan polysulfate sodium (PPS) is a semi-synthetic drug manufactured from the wood chips of European beech trees. Extracted glucuronoxylans are sulfated to produce a negatively charged product that mimics glycosaminoglycans (GAGs). GAGs are complex carbohydrates that play a regulatory role in the body through interacting with proteins involved with inflammation. Key features of PPS activity are its anti-inflammatory and tissue regenerative properties, as well as its mild anti-thrombotic activity.
* TNX-102 SL: Tonix Pharmaceuticals
TNX-102 SL, a sublingual tablet with 2.8 mg of cyclobenzaprine HCl, is taken nightly to treat fibromyalgia. Its rapid absorption and reduced production of a long-lasting active metabolite enhance its effectiveness. This patented formulation optimizes cyclobenzaprine delivery to improve sleep quality and minimize residual effects. TNX-102 SL, a centrally-acting analgesic, eases pain by enhancing sleep. It's currently in mid-Phase III development for fibromyalgia management.
Discover the future of Chronic Pain Treatments with DelveInsight's latest market report. Get expert insights and forecasts-download now! @ Chronic Pain Market Drivers and Barriers [https://www.delveinsight.com/sample-request/chronic-pain-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=ypr]
Chronic Pain Drugs Market
Currently, several types of medications are being used in the management of chronic pain, including acetaminophen, ibuprofen, aspirin, COX-2 inhibitors, antimigraine medications, sedatives, opioids, and antidepressants. Nonpharmacologic treatments for chronic pain can include exercise, physical therapy, counseling, electrical stimulation, biofeedback, acupuncture, hypnosis, chiropractic medicine, and other treatments. There are several approved drugs for the treatment of chronic pain such as EMGALITY (galcanezumab-gnlm), AIMOVIG (erenumab), and AJOVY (fremanezumab), among others.
Chronic Pain Market Outlook
Key Chronic Pain Companies such as Paradigm Biopharmaceuticals, Centrexion Therapeutics, Tonix Pharmaceuticals, and others are evaluating their lead candidates in different stages of clinical development, respectively. They aim to investigate their products for the treatment of Chronic Pain. According to DelveInsight's analysis, the Chronic Pain Market Growth is expected to be mainly driven by increasing Chronic Pain Prevalence, rise in awareness and access to treatment, alternative options (such as a novel therapeutic agent) to addictive opioids, holistic approach, efforts by the organization and upsurge in the geriatric population.
Explore the dynamics of the Chronic Pain Market with DelveInsight. From market size to emerging drugs-find it all in our latest report. Read now! @ Chronic Pain Ongoing Clinical Trials Analysis [https://www.delveinsight.com/sample-request/chronic-pain-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=ypr]
Scope of the Chronic Pain Market Report
* Coverage- 7MM
* Study Period- 2020-2034
* Chronic Pain Companies- AbbVie, Paradigm Biopharmaceuticals Ltd., Noven Pharmaceuticals, Pfizer, Anika Therapeutics, Biogen, Tonix Pharmaceuticals, Taiwan Liposome Company, Centrexion Therapeutics, Braeburn Pharmaceuticals, Regeneron, Teva Pharmaceuticals, Mitsubishi Tanabe Pharma Corporation, Vertanical GmbH, and others.
* Chronic Pain Therapies- Secukinumab, AbobotulinumtoxinA, Rexlemestrocel-L + HA mixture, IncobotulinumtoxinA, Retatrutide, and others.
* Chronic Pain Competitive Intelligence Analysis: SWOT analysis and Market entry strategies
* Chronic Pain Unmet Needs, KOL's views, Analyst's views, Chronic Pain Market Access and Reimbursement
Table of Content
1 Key Insights
2 Report Introduction
3 Chronic Pain Market Overview at a Glance
4 Executive Summary of Chronic Pain
5 Key events
6 Disease Background and Overview
7 Epidemiology and Patient Population
8 Patient Journey
9 Marketed Products
10 Emerging Therapies
11 Chronic Pain: The Seven Major Markets Analysis
12 SWOT Analysis
13 Unmet Needs
14 KOL Views
15 Market Access and Reimbursement
16 Appendix
17 DelveInsight Capabilities
18 Disclaimer
19 About DelveInsight
About Us
DelveInsight is a leading healthcare-focused market research and consulting firm that provides clients with high-quality market intelligence and analysis to support informed business decisions. With a team of experienced industry experts and a deep understanding of the life sciences and healthcare sectors, we offer customized research solutions and insights to clients across the globe. Connect with us to get high-quality, accurate, and real-time intelligence to stay ahead of the growth curve.
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Yash Bhardwaj
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=chronic-pain-therapeutics-market-size-in-the-7mm-is-anticipated-to-increase-by-2034-and-according-to-delveinsight]
Phone: 9650213330
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: Nevada
Country: United States
Website: https://www.delveinsight.com/report-store/lactose-intolerance-market
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Chronic Pain Therapeutics Market Size in the 7MM is anticipated to increase by 2034 and according to DelveInsight here
News-ID: 3828577 • Views: …
More Releases from ABNewswire
Contrarian Watch Company Launches Swiss-Made Luxury Timepieces for Those Who Dar …
Contrarian Watch Company debuts with a mission to redefine accessible luxury through Swiss-made timepieces that blend precision craftsmanship with bold design. The collection targets individuals who refuse to follow trends, offering top-quality watches that make statements this holiday season and beyond.
As holiday shopping season begins and consumers seek meaningful gifts that convey sophistication and thought, a new player in the luxury watch market is challenging industry conventions. Contrarian Watch Company…
Online Boutique The Boujee Sunflower Cultivates Confident Style Through Casual G …
The Boujee Sunflower has spent three to five years perfecting the art of casual glamour for women seeking effortless style. The online fashion boutique curates vibrant, trendy collections that balance laid-back comfort with standout details, serving customers who want to shine with confidence without sacrificing the ease of casual dressing.
In an online retail environment crowded with fashion options ranging from fast fashion to luxury brands, The Boujee Sunflower has carved…
TeeFlow USA Bridges Gym and Street Culture with Motivational Graphics and Premiu …
Targeting Gen Z and Millennials seeking self-expression through apparel, TeeFlow USA offers premium t-shirts serving dual purposes: motivational designs for fitness enthusiasts and bold graphics for streetwear fans. The Florida company differentiates itself with combed ring-spun fabric construction that delivers superior comfort and durability, backed by 100% customer satisfaction guarantee.
The contemporary apparel market presents consumers with seemingly endless options, yet many shoppers struggle to find brands that authentically serve their…
Handcrafted Military Tributes: Black Eagle Handmade Crafts Offers Unique Gifts f …
Black Eagle Handmade Crafts is addressing a unique need in the gift market with its collection of handmade, military-themed home decor items. The veteran-owned business specializes in pipe lamps and upcycled pieces that merge traditional craftsmanship with 3D printing innovation, creating meaningful gifts for military families, veterans, and aviation enthusiasts.
Finding the perfect gift for military personnel, veterans, or military families can be challenging. Generic patriotic merchandise often falls short of…
More Releases for Pain
Comprehensive Pain Management Services Expanded by Denver Pain Management Clinic
Image: https://www.globalnewslines.com/uploads/2025/01/1737464973.jpg
Denver Pain Management Clinic announces expanded services for individuals suffering from chronic pain conditions throughout the Denver metropolitan area. The clinic, established in 2010, continues to strengthen its position as a leading provider of comprehensive pain management services in Colorado through its team of specialized Denver Pain Doctors.
DENVER, CO - October 9, 2025 - Denver Pain Management Clinic [https://denverpainmanagementclinic.com/] announces expanded services for individuals suffering from chronic pain conditions…
Enhanced Pain Relief Solutions at Advanced Pain Care
Image: https://www.globalnewslines.com/uploads/2025/03/3f3b6259bfdec02e5dcb7b9d0c838855.jpg
Advanced Pain Care is helping people who suffer from chronic pain with sophisticated, evidence-based treatments. The clinic is particularly focused on non-surgical care that improves the quality of life. With a team of highly qualified pain experts, they work with patients who have back pain, joint pain, and nerve pain.
Personalized Treatment for Every Pain Disorder
Advanced Pain Care offers treatments depending on the cause of pain. Anyone experiencing arthritis, migraine,…
Pain Finisher | Advanced Pain Relief Device
Pain Finisher is an instant pain relief device that is effective on all pains including back pain and knee pain. It is based on the TENS theory of pain management which is easy to use and safe.
By using Pain Finisher, a modern drug-free and non-invasive pain-relieving treatment method, one can get rid of the common pain creams, gels, and risky treatment methods.
So, have a pain-free life with easy-to-use pain relief…
Neuropathic Pain Market: Innovative Therapies Reshaping Chronic Pain Management
In recent years, the global Neuropathic Pain Market has witnessed a dynamic shift, influenced by changing consumer preferences, technological advancements, and a growing emphasis on sustainability. The Research report on Neuropathic Pain Market presents a complete judgment of the market through strategic insights on future trends, growth factors, supplier landscape, demand landscape, Y-o-Y growth rate, CAGR, pricing analysis. It also provides and a lot of business matrices including…
Visceral Pain Market Analysis 2024: Addressing Pain Management Challenges
The Business Research Company has released its latest global market reports, covering insights for 2024 and offering projections up to 2033.
The Business Research Company presents an extensive market research report on the Visceral Pain Global Market Report 2024, furnishing businesses with a competitive edge through a detailed examination of the market structure, encompassing estimates for various segments and sub-segments.
Furthermore, the report highlights on emerging trends, significant drivers, challenges, and opportunities,…
Global Post-Operative Pain Management Market: Pain Relief Goes Worldwide
Introduction:
The Global Post-Operative Pain Management Market is growing at a rapid pace. This market involves the management of pain after surgical procedures. The market has witnessed significant growth in recent years, owing to the increasing number of surgeries and the rising prevalence of chronic diseases. Pain management is an essential aspect of healthcare, as uncontrolled pain can lead to prolonged hospital stays, delayed recovery, and poor patient outcomes.
In this article,…
